Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 859-866

  Zhaoa, F L ^a   Hua, G D ^a   Wang, X F ^a   Zhang, X H ^a   Zhang, Ya kui ^a   Yu, Z S ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bone metastasis; Breast cancer; MicroRNA 10B; Serum

Indexed keywords

MICRORNA 10B;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84863096001     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000304     Document Type: Article

References (38)

1. Lipton A: Bone metastases in breast cancer. Curr Treat Options Oncol 2003; 4: 151-158.
2. Coleman RE: Metastastic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27: 165-176.
3. Altundag O, Altundag K, Selim Silay Y, et al: Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis. Med Hypotheses 2004; 63: 1010-1013.
4. Roodman GD: Mechanisms of bone metastasis. N Engl J Med 2004; 350: 1655-1664.
5. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
6. Jørgensen KJ, Zahl PH, Gøtzsche PC: Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010; 340: c1241.
7. Munagala R, Aqil F, Gupta RC: Promising molecular targeted therapies in breast cancer. Indian J Pharmacol 2011; 43: 236-245.
8. Huang Q, Ouyang X: Biochemical-markers for the diagnosis of bone metastasis: a clinical review. Cancer Epidemiol 2012; 36: 94-98.
9. Costelloe CM, Rohren EM, Madewell JE, et al: Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 2009; 10: 606-614.
10. Uehara M, Kinoshita T, Hojo T, et al: Long-term prognostic study of carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA 15-3) in breast cancer. Int J Clin Oncol 2008; 13: 447-451.
11. Weigelt B, Peterse JL, van't Veer LJ: Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602.
12. Goswami RS, Waldron L, Machado J, et al: Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples. BMC Biotechnol 2010; 10: 47.
13. Lee YS, Kim HK, Chung S, et al: Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 2005; 280: 16635-16641.
14. Ivanovska I, Ball AS, Diaz RL, et al: MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28: 2167-2174.
15. Kobayashi T, Lu J, Cobb BS, et al: Dicerdependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA 2008; 105: 1949-1954.
16. Huang Q, Gumireddy K, Schrier M, et al: The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202-210.
17. Zibert JR, Løvendorf MB, Litman T, et al: MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010; 58: 177-185.
18. Ma L: Role of miR-10b in breast cancer metastasis. Breast Cancer Res 2010; 12: 210.
19. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688.
20. Edmonds MD, Hurst DR, Vaidya KS, et al: Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 2009; 125: 1778-1785.
21. Chai G, Liu N, Ma J, et al: MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 2010; 101: 1997-2004.
22. Li G, Wu Z, Peng Y, et al: MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 2010; 299: 29-36.
23. Weiss FU, Marques IJ, Woltering JM, et al: Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009; 137: 2136-2145.
24. Tian Y, Luo A, Cai Y, et al: MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010; 285: 7986-7994.
25. Zurrida S, Veronesi U: A new TNM classification for breast cancer to meet the demands of the present and the challenges of the future. Womens Health (Lond Engl) 2011; 7: 41-49.
26. Boxer DI, Todd CE, Coleman R, et al: Bone secondaries in breast cancer: the solitary metastasis. J Nucl Med 1989; 30: 1318-1320.
27. Kubo A, Momoshima S, Shiga H: Diagnostic imaging of bone metastasis from breast cancer. Breast Cancer 1997; 4: 306-310.
28. Brase JC, Wuttig D, Kuner R, et al: Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010; 9: 306.
29. Chen C, Ridzon DA, Broomer AJ, et al: Realtime quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179.
30. Heneghan HM, Miller N, Lowery AJ, et al: Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499-505.
31. Gramantieri L, Ferracin M, Fornari F, et al: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67: 6092-6099.
32. Yan LX, Huang XF, Shao Q, et al: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14: 2348-2360.
33. Sasayama T, Nishihara M, Kondoh T, et al: MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 2009; 125: 1407-1413.
34. Bloomston M, Frankel WL, Petrocca F, et al: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-1908.
35. Huse JT, Brennan C, Hambardzumyan D, et al: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23: 1327-1337.
36. Yang JL, Zhu NS, Wang Y, et al: Protein and mRNA characterization in high and low metastasis adenoid cystic carcinoma cell lines. Mol Biol Rep 2004; 31: 241-248.
37. Baffa R, Fassan M, Volinia S, et al: MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009; 219: 214-221.
38. Gee HE, Camps C, Buffa FM, et al: MicroRNA-10b and breast cancer metastasis. Nature 2008; 455: E8-E9.